Genix Pharmaceuticals Corporation (TSXV:GENX)

Canada · Delayed Price · Currency is CAD

0.0150

0.00 (0.00%)

At close: Jul 6, 2026

Genix Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Cash & Equivalents	0.01	0.04	0.01	0.01	0.01	0.14
Cash & Short-Term Investments	0.01	0.04	0.01	0.01	0.01	0.14
Cash Growth	161.68%	279.69%	-1.30%	25.51%	-93.32%	-80.07%
Accounts Receivable	0	0	0.01	0	0.02	0
Inventory	-	-	-	0.16	0.17	0
Other Current Assets	0.02	0.01	0.02	0.04	0.04	0.04
Total Current Assets	0.03	0.05	0.04	0.22	0.24	0.19
Net Property, Plant & Equipment	-	-	-	-	0	0.03
Other Intangible Assets	0	0	0.01	0.01	4.01	4.55
Total Assets	0.03	0.05	0.04	0.22	0.24	0.19

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Accounts Payable	0.19	0.18	0.17	0.27	0.23	0.04
Current Portion of Long-Term Debt	1.15	1.04	0.82	0.51	0.18	0.02
Current Portion of Leases	-	-	-	-	0	0.02
Other Current Liabilities	0.24	0.25	0.24	0.58	0.64	0.66
Total Current Liabilities	1.58	1.47	1.23	1.36	1.05	0.74
Long-Term Leases	-	-	-	-	-	0.01
Total Long-Term Liabilities	-	-	-	-	-	0.01
Total Liabilities	1.58	1.47	1.23	1.36	1.05	0.76

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Common Stock	9.76	9.76	9.7	9.7	9.7	9.7
Additional Paid-in Capital	1.36	1.36	1.32	1.29	1.23	0.97
Retained Earnings	-12.67	-12.54	-12.2	-12.13	-7.74	-6.66
Shareholders' Equity	-1.55	-1.42	-1.18	-1.14	3.2	4.01
Total Liabilities & Equity	0.03	0.05	0.05	0.22	4.25	4.77

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Total Debt	1.15	1.04	0.82	0.51	0.18	0.05
Net Cash (Debt)	-1.14	-1	-0.8	-0.5	-0.17	0.09
Net Cash Growth	-	-	-	-	-	-86.81%
Net Cash Per Share	-0.02	-0.02	-0.01	-0.01	-0.00	0.00
Book Value	-1.55	-1.42	-1.18	-1.14	3.2	4.01
Book Value Per Share	-0.03	-0.02	-0.02	-0.02	0.05	0.07
Tangible Book Value	-1.55	-1.42	-1.19	-1.15	-0.81	-0.53
Tangible Book Value Per Share	-0.03	-0.02	-0.02	-0.02	-0.01	-0.01